This FDA InspectorProfile is a report of relevant audit-related information on Dongping Dai, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Dongping Dai's inspections in 7 countries: United States, China, United Kingdom, Singapore, France, Denmark, and India.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Dongping Dai's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Dongping Dai.
Note: The EIR and 483 documents are sold separately.